3-[2-[1-(4-fluoro-3-methylphenyl)-5-hydroxy-2-propan-2-ylindol-3-yl]ethyl]-3-methylcyclobutane-1-carboxylic acid
C26H30FNO3 — CID 156877275
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-[1-(4-fluoro-3-methylphenyl)-5-hydroxy-2-propan-2-ylindol-3-yl]ethyl]-3-methylcyclobutane-1-carboxylic acid
3-[2-[1-(4-fluoro-3-methylphenyl)-5-hydroxy-2-propan-2-ylindol-3-yl]ethyl]-3-methylcyclobutane-1-carboxylic acid (PubChem CID 156877275) has the molecular formula C26H30FNO3 and a molecular weight of 423.53 g/mol. Its IUPAC name is 3-[2-[1-(4-fluoro-3-methylphenyl)-5-hydroxy-2-propan-2-ylindol-3-yl]ethyl]-3-methylcyclobutane-1-carboxylic acid.
Molecular Properties
| Compound Name | 3-[2-[1-(4-fluoro-3-methylphenyl)-5-hydroxy-2-propan-2-ylindol-3-yl]ethyl]-3-methylcyclobutane-1-carboxylic acid |
|---|---|
| PubChem CID | 156877275 |
| Molecular Formula | C26H30FNO3 |
| Molecular Weight | 423.53 g/mol |
| Exact Mass | 423.22 |
| IUPAC Name | 3-[2-[1-(4-fluoro-3-methylphenyl)-5-hydroxy-2-propan-2-ylindol-3-yl]ethyl]-3-methylcyclobutane-1-carboxylic acid |
| SMILES | Cc1cc(-n2c(C(C)C)c(CCC3(C)CC(C(=O)O)C3)c3cc(O)ccc32)ccc1F |
| InChI | InChI=1S/C26H30FNO3/c1-15(2)24-20(9-10-26(4)13-17(14-26)25(30)31)21-12-19(29)6-8-23(21)28(24)18-5-7-22(27)16(3)11-18/h5-8,11-12,15,17,29H,9-10,13-14H2,1-4H3,(H,30,31) |
| InChIKey | CCJFWSHDUZOFEQ-UHFFFAOYSA-N |
| XLogP | 6.34 |
| TPSA | 62.46 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 423.53 |
| LogP ≤ 5 | 6.34 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156877275 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.